Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Liles, DK; Shah, NR; Scullin, B; Gordeuk, VR; Smith, WR; Kanter, J; Achebe, MM; Boccia, R; Crary, SE; Kraft, WK; Archer, N; Cataldo, V; Hardesty, BM; Idowu, M; Desai, PC; Ikeda, A; Puthenveetil, G; Hassell, KL; Sarnaik, S; Kutlar, A

Published Date

  • November 2021

Published In

Volume / Issue

  • 195 / 4

Start / End Page

  • e150 - e153

PubMed ID

  • 34611900

Electronic International Standard Serial Number (EISSN)

  • 1365-2141

Digital Object Identifier (DOI)

  • 10.1111/bjh.17739

Language

  • eng

Conference Location

  • England